| 9th Aug 2022 12:05 pm |
RNS |
Achilles reports Q2 2022 Financial Results |
| 9th Aug 2022 12:05 pm |
RNS |
Freeline reports Q2 2022 Financial Results |
| 4th Aug 2022 12:07 pm |
RNS |
Autolus Reports Q2 2022 Financial Results |
| 3rd Aug 2022 1:15 pm |
RNS |
Holding(s) in Company |
| 2nd Aug 2022 12:28 pm |
RNS |
Result of AGM |
| 2nd Aug 2022 7:00 am |
RNS |
Total Voting Rights |
| 15th Jul 2022 7:00 am |
RNS |
Issue of shares pursuant to incentive scheme |
| 11th Jul 2022 7:00 am |
RNS |
Freeline presents data in haemophilia B |
| 7th Jul 2022 9:41 am |
RNS |
Holding(s) in Company |
| 30th Jun 2022 9:00 am |
RNS |
Publication of 2022 Annual Report & Notice of AGM |
| 22nd Jun 2022 5:21 pm |
RNS |
Director Declaration |
| 16th Jun 2022 7:00 am |
RNS |
Final Results |
| 10th Jun 2022 8:05 am |
RNS |
Autolus presents clinical data updates at EHA |
| 8th Jun 2022 2:33 pm |
RNS |
Holding(s) in Company |
| 19th May 2022 7:00 am |
RNS |
Notice of Results |
| 18th May 2022 11:05 am |
RNS |
Syncona invests in $56 million SwanBio Series B |
| 12th May 2022 4:00 pm |
RNS |
Autolus to present clinical data at EHA Congress |
| 11th May 2022 7:00 am |
RNS |
Freeline reports Q1 2022 Financial Results |
| 10th May 2022 1:02 pm |
RNS |
Achilles reports Q1 2022 Financial Results |
| 5th May 2022 12:05 pm |
RNS |
Autolus Reports Q1 2022 Financial Results |
| 28th Apr 2022 7:00 am |
RNS |
Syncona invests in £75.5 million OMass Series B |
| 11th Apr 2022 7:00 am |
RNS |
Anaveon announces initial clinical data |
| 4th Apr 2022 12:34 pm |
RNS |
Director/PDMR Shareholding |
| 1st Apr 2022 7:00 am |
RNS |
Freeline reports Full Year 2021 Financial Results |
| 24th Mar 2022 4:11 pm |
RNS |
Holding(s) in Company |
| 23rd Mar 2022 8:30 am |
RNS |
Freeline enters into ADS purchase agreement |
| 11th Mar 2022 7:00 am |
RNS |
Freeline registered direct offering |
| 10th Mar 2022 12:05 pm |
RNS |
Autolus Reports Full Year 2021 Financial Results |
| 9th Mar 2022 4:39 pm |
RNS |
Director/PDMR Shareholding |
| 9th Mar 2022 3:09 pm |
RNS |
Holding(s) in Company |
| 7th Mar 2022 5:29 pm |
RNS |
Director/PDMR Shareholding |
| 1st Mar 2022 12:56 pm |
RNS |
Achilles reports Full Year 2021 Results |
| 18th Feb 2022 7:00 am |
RNS |
Completion of sale of Gyroscope Therapeutics |
| 8th Feb 2022 12:05 pm |
RNS |
Freeline presents data in Fabry disease |
| 31st Dec 2021 7:00 am |
RNS |
Directorate Change |
| 22nd Dec 2021 7:00 am |
RNS |
Gyroscope to be acquired for up to $1.5 billion |
| 16th Dec 2021 7:00 am |
RNS |
Syncona cornerstones Anaveon Series B |
| 14th Dec 2021 7:00 am |
RNS |
Freeline reports 2022 priorities and guidance |
| 13th Dec 2021 2:05 pm |
RNS |
Freeline presents data in haemophilia B |
| 13th Dec 2021 12:05 pm |
RNS |
Autolus presents positive AUTO1 (obe-cel) data |
